Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
103.6 USD | +0.98% |
|
-1.24% | -5.26% |
06-27 | Barclays Trims Price Target on Revvity to $115 From $116 | MT |
06-20 | Bionano Genomics Says Revvity to Commercialize VIA Software | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.26% | 12.78B | |
+1.75% | 206B | |
+3.42% | 177B | |
+31.54% | 157B | |
+32.16% | 112B | |
+1.71% | 64.63B | |
+21.08% | 55.63B | |
-1.61% | 47.57B | |
-9.11% | 36.87B | |
-0.34% | 35.18B |
- Stock Market
- Equities
- RVTY Stock
- News Revvity, Inc.
- Transcript : PerkinElmer, Inc. Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-10-2023 08